Counterelectrophoresis (CEP) and immunodiffusion (ID) were evaluated prospectively as methods for the early and rapid laboratory diagnosis of California encephalitis (CE). CEP and ID studies were done on paired sera from 127 patients with acute central nervous system infections. After the precipitin tests were completed, conventional hemagglutination-inhibition, neutralizing, and complement fixing antibody titers were measured. The CEP system detected antibodies in 7 (41%) of 17 CE patients during their acute illness and in all 17 patients during convalescence. The ID method was less sensitive; 3 of 17 acute sera and 16 of 17 convalescent sera were ID positive. Comparative precipitin studies indicated that La Crosse virus was the infecting California group subtype in all 17 CE patients. Because CEP can be performed in 1.5 h, is at least as sensitive as hemagglutination-inhibition, neutralizing, and complement fixing tests, and can detect prospectively 41% of CE patients during their acute illness, it is recommended as a rapid diagnostic test for CE.
California encephalitis (CE) has been recognized in the United States since 1960, and more than 500 cases of CE have been reported from 18 states during the past decade (2, 4) . Sixty-six of these cases have occurred in Minnesota children (2) . Early and rapid diagnosis of CE is especially important, since the initial clinical course may closely resemble Herpesvirus hominis encephalitis (2, 5) . In a previous retrospective study, we reported that immunodiffusion (ID) and counterelectrophoresis (CEP) were rapid methods that would be useful for the early detection of some CE patients (1) . The purpose of the present investigation was to evaluate these methods prospectively.
MATERIALS AND METHODS
Five low-passaged California group arboviruses, which included four prototypes and one Minnesota La Crosse strain, were used as seed viruses to prepare ID and CEP antigens. Prototype La Crosse, snowshoe hare, Jamestown Canyon, and Trivittatus viruses were kindly supplied by W. H. Thompson, Madison, Wisconsin. La Crosse strain Z-7-71 was isolated by us from a pool of four Aedes triseriatus mosquitoes collected in Zumbra Ridge, Minnesota, in August, 1971. It was identified as a La Crosse subtype by comparative tissue culture neutralization (Nt) and complement fixation (CF) testing (3), using antisera obtained from W. H. Thompson and the National Center for Disease Control. The precipitin and immunizing antigens and the control rabbit antisera for ID and CEP studies were made as previously detailed (1) .
Throat swabs, stools, cerebrospinal fluids, and brain biopsy specimens were processed for virus isolation as previously described 12). If a virus was isolated, the patient's sera were tested for Nt antibodies to the homologous virus.
Venous blood was drawn from patients by sterile techniques and allowed to clot at room temperature. The sera were separated by centrifugation and stored in glass screw-capped vials at -70 C until tested. During the months of June through October, 1973, acute sera from 127 Minnesota patients with clinical diagnoses of central nervous system infections were tested by ID and CEP as soon as they were received. After the convalescent serum was obtained, the acute and convalescent sera were tested simultaneously for precipitin antibodies. When the precipitin studies were completed, the paired sera were tested for La Crosse hemagglutination-inhibition (HI), Nt, CF, Herpesvirus hominis type 1 CF, mumps CF, and Western equine encephalitis HI antibodies using standard procedures (3). The serologic diagnosis was based on a fourfold or greater change in HI, Nt, and/or CF titers. Comparative ID and CEP were done on the sera from CE patients to determine the infecting California arbovirus subtype as previously described (1) .
The ID tests were done using a micro-slide technique described by Wellings, Sather, and Hammon with minor modifications (6 days; median, 6 days). The 10 precipitin-negative specimens were collected 1 to 6 days after the onset of illness (mean, 3.1 days; median, 3.0 days). The earliest that a specimen was positive was the day of the onset of illness. No correlation could be made between early sero-positivity and the severity of the patient's clinical course.
DISCUSSION
There are several features of CE that render clinical recognition difficult and, thus, make early and rapid laboratory diagnosis desirable. First, patients with CE may have an early clinical course which is indistinguishable from that of Herpesuirus hominis encephalitis (2, 5) . Patients with Herpesvirus hominis encephalitis might be treated with toxic deoxyribonucleic acid antagonists that have not been shown to be effective against the California arbovirus group. A rapid diagnosis of CE would militate against the decision to use these antiviral agents. Also, the diagnosis of herpes encephalitis may require a brain biopsy and in one instance a Minnesota patient with California encephalitis was subjected to a brain biopsy because the working diagnosis was Herpesvirus hominis encephalitis (2) . Early and rapid diagnosis of CE might spare these patients such invasive procedures.
Second, patients with CE frequently have a leukocytosis which may be as high as 30,000 cells per mm', and they may also have a predominance of polymorphonuclear cells in their spinal fluid (2) . The peripheral leukocytosis and presence of polymorphonuclear cells in the spinal fluid suggests bacterial meningitis, and the majority of our patients with CE initially have been treated with antibacterial gents. A rapid laboratory diagnosis of CE would enable the physician not to use or to discontinue antibacterial therapy.
In a retrospective study conducted on 40 patients with California encephalitis, we showed that precipitin antibody tests were useful for the laboratory diagnosis of CE and could detect between 36 to 44% of patients during the acute illness (1). Precipitin antibodies were particularly useful for early diagnosis because they were found only in patients with CE, whereas HI, Nt, and CF antibodies occurred in individuals without a history of CE (1). In addition, precipitin antibodies disappeared in all but one instance within a year after the onset of CE (1) . Because CE has occurred only in the summer months in the United States (4), and because most patients with CE become precipitin negative within a year of illness, the presence of precipitin antibodies in an acute or convalescent specimen from a patient with a viral central nervous system infection is essentially diagnostic of CE.
Seven (41%) of 17 patients with CE in this present prospective study had precipitins in their acute sera. Thus, an early diagnosis of CE was made in those patients. The earliest that an acute serum was positive was the day of onset of illness. In that child, the physician was phoned and given the presumptive laboratory diagnosis. Because that particular patient had a clinical course which was believed to be most compatible with herpesvirus encephalitis, transfer of the patient to another institution with consideration of performing a brain biopsy had been planned. The patient remained at the community hospital following the presumptive diagnosis of CE and she made a rapid recovery from her meningoencephalitis after 3 days of intensive care.
The CEP test detected all of the 17 patients who had a subsequent laboratory diagnosis of CE based on conventional tests. Hence, the CEP system appears to be at least as sensitive as HI, Nt, and CF tests for the detection of CE antibody. However, in one patient in the present prospective study and in another in the retrospective study, it was found that precipitin antibodies developed late (8 to 16 weeks after onset of illness). If a viral diagnosis cannot be established using a convalescent serum obtained 3 to 4 weeks after the onset of illness, it might be of value to draw a third specimen 4 to 8 weeks later.
In this prospective study, the CEP method appeared to be more sensitive than the ID method. The ID system did not detect 4 of the 7 acute sera and 1 of the 17 convalescent sera which were CEP positive. Because the CEP system appears to be somewhat more sensitive than ID and because it can be performed in 1.5 h whereas ID requires 24 h, we consider the CEP method the laboratory test of choice for the rapid detection of CE antibody.
